IP Library Granted Patent US 7,008,644
Granted Patent B2
US 7,008,644 · App. 10/101,563 · Granted Mar 7, 2006

Method and apparatus for producing dry particles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,008,644
App. No.
10/101,563
Granted
Mar 7, 2006
Kind
B2
Abstract

Method and apparatus for producing dry particles. Two liquid components are combined in a static mixer, atomized into droplets, and the droplets dried to form dry particles. Use of the static mixer enables incompatible liquid components to be rapidly and homogeneously combined. The present invention optimizes process conditions for increasing and controlling particle porosity. The present invention also allows for optimization of particle size in real-time during particle production.

Claims (9)

1. A method for preparing a dry powder composition, comprising:

combining a first phase and a second phase in a static mixer to form a combination wherein the first phase comprises human growth hormone and sodium phosphate, and the second phase comprises ethanol and ammonium bicarbonate;

atomizing the combination to produce droplets; and

drying the droplets to form dry particles.

2. The method of claim 1 , wherein the second phase further comprises 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC).

3. A dry powder composition prepared by the method of claim 1 .

4. The dry powder composition of claim 3 , wherein the dry particles consist essentially of 93.5% human growth hormone and 6.5% sodium phosphate by weight of total human growth hormone and sodium phosphate.

5. A dry powder composition prepared by the method of claim 1 , wherein the dry particles consist essentially of 80% human growth hormone, 6% sodium phosphate, and 14% DPPC by weight of total human growth hormone, sodium phosphate, and DPPC.

6. A unit dose of a dry powder composition comprising a unit dose receptacle having a therapeutically effective amount of dry powder composition formed according to the method of claim 1 .

Assignments (3)
CHANGE OF NAME Recorded May 6, 2011
From: CORREGIDOR THERAPEUTICS, INC.
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 026240/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2011
From: ALKERMES, INC.
To: CORREGIDOR THERAPEUTICS, INC.
Reel/Frame 026095/0392 →
MERGER Recorded Jul 24, 2007
From: ADVANCED INHALATION RESEARCH, INC.
To: ALKERMES, INC.
Reel/Frame 019606/0187 →